Importantly, we found that mifepristone treatment across SMA animal models, including severe Smn-/-;SMN2 SMA mice, milder Smn2B/- SMA mice and a severe C. elegans SMA model, significantly improved disease phenotypes such as survival, muscle size and neuromuscular function. Here, SMN2 is linked to proximal spinal muscular atrophy.